by shannon | Apr 5, 2023 | News and Events
Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”) and Celltrion Asia Pacific Pte., Ltd. (“Celltrion”), a subsidiary of Celltrion Group Inc, have today announced their partnership to contract manufacture and commercialize a range of oral dosage form drugs (OSD)...
by shannon | Mar 9, 2023 | Articles
Importance of equipment reliability Successfully manufacturing a drug product requires people, proper equipment, and materials. It’s the classic three-legged stool analogy. Even with well-trained staff and high-quality materials, if the equipment does not function as...
by shannon | Mar 1, 2023 | Articles
Extrusion Spheronization’s Expanding Influence as a Drug Manufacturing Driver Widely acknowledged as a predictable vehicle for the control, distribution and transportation of therapeutic agents around the body, E-S engineered formulations make a variety of common and...
by shannon | Mar 1, 2023 | News and Events
Join the Bora Team! Bora Group, is partnering with leading universities in Taiwan to meet with students who are interested in joining the clinical development and manufacturing industry. Bora has invested heavily in growth over the last 5 years and has high demand for...
by shannon | Feb 22, 2023 | News and Events, Press Mentions
Contract Pharma features this engaging article: “Extrusion-Spheronization in OSD Manufacturing. How extrusion-spheronization excels delivering controlled and modified release dose forms.” Published on February 21, 2023Contract Pharma In this article Bora...
